Purified native Type 1 Collagen Extracellular Matrix with Polyhexamethylene Biguanide Antimicrobial (PCMP)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Purified native Type 1 Collagen Extracellular Matrix with Polyhexamethylene Biguanide Antimicrobial (PCMP), covering 2025-04-04 to 2025-04-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers [NA]